Cargando…
New Therapies of Liver Diseases: Hepatic Encephalopathy
Hepatic encephalopathy (HE) is a common complication of advanced liver disease which has profound implications in terms of the patients’ ability to fulfil their family and social roles, to drive and to provide for themselves. Recurrent and persistent HE is still a serious management challenge, trans...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472037/ https://www.ncbi.nlm.nih.gov/pubmed/34575157 http://dx.doi.org/10.3390/jcm10184050 |
_version_ | 1784574625018019840 |
---|---|
author | Mangini, Chiara Montagnese, Sara |
author_facet | Mangini, Chiara Montagnese, Sara |
author_sort | Mangini, Chiara |
collection | PubMed |
description | Hepatic encephalopathy (HE) is a common complication of advanced liver disease which has profound implications in terms of the patients’ ability to fulfil their family and social roles, to drive and to provide for themselves. Recurrent and persistent HE is still a serious management challenge, translating into a significant burden for patients and their families, health services and society at large. The past few years have been characterized by significantly more attention towards HE and its implications; its definition has been refined and a small number of new drugs/alternative management strategies have become available, while others are underway. In this narrative review we summarize them in a pragmatic and hopefully useful fashion. |
format | Online Article Text |
id | pubmed-8472037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84720372021-09-28 New Therapies of Liver Diseases: Hepatic Encephalopathy Mangini, Chiara Montagnese, Sara J Clin Med Review Hepatic encephalopathy (HE) is a common complication of advanced liver disease which has profound implications in terms of the patients’ ability to fulfil their family and social roles, to drive and to provide for themselves. Recurrent and persistent HE is still a serious management challenge, translating into a significant burden for patients and their families, health services and society at large. The past few years have been characterized by significantly more attention towards HE and its implications; its definition has been refined and a small number of new drugs/alternative management strategies have become available, while others are underway. In this narrative review we summarize them in a pragmatic and hopefully useful fashion. MDPI 2021-09-07 /pmc/articles/PMC8472037/ /pubmed/34575157 http://dx.doi.org/10.3390/jcm10184050 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mangini, Chiara Montagnese, Sara New Therapies of Liver Diseases: Hepatic Encephalopathy |
title | New Therapies of Liver Diseases: Hepatic Encephalopathy |
title_full | New Therapies of Liver Diseases: Hepatic Encephalopathy |
title_fullStr | New Therapies of Liver Diseases: Hepatic Encephalopathy |
title_full_unstemmed | New Therapies of Liver Diseases: Hepatic Encephalopathy |
title_short | New Therapies of Liver Diseases: Hepatic Encephalopathy |
title_sort | new therapies of liver diseases: hepatic encephalopathy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472037/ https://www.ncbi.nlm.nih.gov/pubmed/34575157 http://dx.doi.org/10.3390/jcm10184050 |
work_keys_str_mv | AT manginichiara newtherapiesofliverdiseaseshepaticencephalopathy AT montagnesesara newtherapiesofliverdiseaseshepaticencephalopathy |